PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | |infection |
| Sentences | 596 |
| PubMedID- 22530052 | These include infection with the hepatitis b virus (hbv) or c virus (hcv), heavy alcohol consumption, diabetes, obesity, ingestion of aflatoxin or fumonisin, metabolic syndrome, nonalcoholic steatohepatitis and several rare exposures and metabolic disorders (hemochromatosis, α-1 antitrypsin deficiency, porphyrias) , , . |
| PubMedID- 22242973 | Introduction: the nucleotide analogue adefovir dipivoxil (adv) was approved in 2002 for the treatment of chronic infection with hepatitis b virus (hbv), in both hepatitis b e antigen (hbeag)-positive and -negative patients. |
| PubMedID- 23041743 | Anti-hev igm seropositivity rate ranging from 3.2 to 31 per cent in hbsag carriers has been reported in different studies1430 and hepatitis e has also been suspected to cause super-infection in carriers of hepatitis b31. |
| PubMedID- 24635942 | In egypt, the absence of alcohol is favorable to patients, while co-infection with bilharzias, hepatitis b or overweight, increase the risk of complications. |
| PubMedID- 23070749 | Purpose: concurrent infection with hiv, hepatitis b virus (hbv), and hepatitis c virus (hcv) often occurs due to the commonality in risk factors for acquisition. |
| PubMedID- 25736100 | In japan, the incidence of infection with hepatitis b virus (hbv) and hepatitis c virus (hcv) is decreasing, and continued drug development is contributing to the control of viral hepatitis-induced hepatocellular carcinoma (hcc).1 however, the incidence of non-viral hepatitis (e.g. |
| PubMedID- 26411126 | infection with hepatitis b and c viruses was detected in 39.5% (58) male patients and 60.5% (89) female patients. |
| PubMedID- 23024757 | Among them, chronic infection with hepatitis b virus (hbv) is one of the major etiological factors for developing hcc with considerable regional variations ranging from 20% of hcc cases in japan to 65% in china 3. |
| PubMedID- 26062906 | infection with hepatitis b virus (hbv) remains a worldwide health problem, and dna-based vaccines against hbv have been tested for therapeutic applications. |
| PubMedID- 21682827 | Although chronic infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) are the most important risk factors for the development of hepatocellular carcinoma (hcc) worldwide, the proportion of hcc patients negative for the hepatitis b surface antigen and hepatitis c antibody, so-called "non-b non-c hcc", is rapidly increasing, especially in japan. |
| PubMedID- 26517979 | Aim: we identified four cases of infection with hepatitis b virus genotype g and a2 recombinant (hbv/g/a2) strains, which were initially overlooked by enzyme immunoassay-based genotyping. |
| PubMedID- 21349948 | The etiology of the liver disease was categorized as infection with hepatitis b (hbv), hcv, alcoholic liver disease, nonalcoholic fatty liver disease, hemochromatosis, autoimmune hepatitis, and primary biliary cirrhosis. |
| PubMedID- 23039099 | Epidemiologic and experimental evidence has shown that chronic infection with hepatitis b and c virus (hbv, hcv) is a major risk factor for hepatocellular carcinoma (hcc). |
| PubMedID- 23100194 | Worldwide, the major risk factors for hcc are infection with the hepatitis b (hbv) and hepatitis c (hcv) viruses. |
| PubMedID- 21108341 | The prevalence of infection with hepatitis b virus in portugal is around 1% of the population; 20-30% of those infected typically develop cirrhosis. |
| PubMedID- 20697376 | Gene-profiling studies of human hepatocellular carcinomas (hccs) demonstrate hh pathway activation in hccs related to chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv). |
| PubMedID- 23162603 | The geographic variation in hcc incidence might be due to geographic differences in the prevalence of various etiological factors, particularly chronic infection with hepatitis b and/or c virus, and dietary exposure to aflatoxins (2). |
| PubMedID- 24463828 | This study investigated risk factors and time-trends of the seroprevalence of cytomegalovirus (cmv), toxoplasmosis and hepatitis a total antibody; and co-infection with syphilis, hepatitis b and hepatitis c among newly diagnosed hiv individuals in singapore. |
| PubMedID- 21814611 | These findings suggest that de novo hepatitis b can develop in patients with hcv infection during the post-olt period despite the presence of protective anti-hbs. |
| PubMedID- 20642705 | Risk factors for the development of hcc have been well documented and include the presence of cirrhosis, infection with hepatitis b and c viruses, heavy alcohol intake, diabetes and obesity (1,2). |
| PubMedID- 24807840 | Hepatocellular carcinoma (hcc) is thefifth most common cancerworldwide and is the third leading cause of cancer-related mortality.1 approximately 80–90% of hcc patients haveunderlying liver cirrhosis, which is characterized by tissue fibrosisand the conversion of normal liver architecture into structurallyabnormal nodules.2 the major risk factorsfor developing cirrhosis and hcc are infection with hepatitis b (hbv)or hepatitis c (hcv) virus and excessive alcohol consumption (alc).3 a strong positive correlation has been demonstratedbetween hcc incidence rates and liver cirrhosis, showing that patientswith hbv-related cirrhosis have a 1000-fold greater risk of developinghcc, whereas hcv-related cirrhosis carries the highest risk of developinghcc in the united states.1,4 therefore, it is importantto identify biomarkers for the early detection of hcc and predictionof disease progression in patients suffering from cirrhosis. |
| PubMedID- 24116040 | A total of 17 eligible studies were involved, including 2151 healthy controls (hc), 1293 spontaneous recovered (sr) patients with acute infection, 2337cases with chronic hepatitis b (chb) and 554 cases with progressive hepatitis b. there was no evidence of significant association between mbl2 exon1 polymorphisms and chb risk in any genetic model or pairwise comparisons when compared with hc group or sr group. |
| PubMedID- 21160955 | Aim: to determine the seroprevalence of hepatitis c virus (hcv) and its co-infection with hepatitis b virus (hbv), hepatitis delta agent (hdv) and human immunodeficiency virus (hiv) among liver disease patients of south tamil nadu. |
| PubMedID- 22855664 | Viral markers showed evidence of previous hepatitis a exposure and no active or previous infection with hepatitis b or c viruses. |
| PubMedID- 23373034 | Introduction: the infection with the hepatitis b virus (hbv) is a global health problem which affects 2 billion people worldwide. |
| PubMedID- 21760875 | Two years later, progressive cholestasis appeared in blood test and infection with hepatitis b and hepatitis c virus was ruled out. |
| PubMedID- 22611419 | In chronic infection with hepatitis b virus or hcv, specific ctls are few and engage few specific targets; they also display anergic characteristics with reduced type 1 cytokine secretion . |
| PubMedID- 22041528 | infection with hepatitis b and c virus (hbv and hcv, respectively) and hepatocellular carcinoma (hcc) are responsible for heavy disease burdens in china. |
| PubMedID- 21883273 | Background and objectives: blood can be infectious if it is donated shortly before infection with hepatitis b virus (hbv), hepatitis c virus (hcv) or human immunodeficiency virus (hiv) becomes detectable. |
| PubMedID- 22768303 | We formulated a model of immune tolerance during chronic infection with hepatitis b virus. |
| PubMedID- 24376578 | Previous epidemiological studies have identified that major risk factors for the development of hcc are chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), liver cirrhosis, habitual alcohol abuse, and exposure to aflatoxin b1 . |
| PubMedID- 21060813 | Chronic infection with hepatitis b virus (hbv) could lead to cirrhosis and highly malignant liver cancer. |
| PubMedID- 25928043 | In the setting of hiv infection, immunization with hepatitis b virus (hbv) vaccine is essential in order to prevent liver-related morbidity and mortality than can occur with hbv co-infection . |
| PubMedID- 21166097 | The relative importance of infection with hepatitis b virus (hbv) and hepatitis c virus (hcv) is unclear. |
| PubMedID- 21760978 | infection with hepatitis b or c virus is one of the major risk factors for hcc, along with cirrhosis, and exposure to aflatoxin, a highly mutagenic fungal compound often found in stores of contaminated grains or nuts . |
| PubMedID- 23875004 | They included age, sex, body weight, body mass index (bmi), baseline laboratory data cd4 cell count, hiv viral load, estimated glomerular filtration rate (egfr), and presence or absence of other medical conditions concurrent use of tenofovir (tdf), co-infection with hepatitis b, defined by positive hepatitis b surface antigen, and co-infection with hepatitis c, defined by positive hepatitis c viral load. |
| PubMedID- 22066022 | Most hccs develop in fibrotic or already cirrhotic liver which are a result of chronic infection with hepatitis b (hbv) or hepatitis c virus (hcv) 1. |
| PubMedID- 26491442 | infection with hepatitis b virus (hbv) is a major risk factor for hepatocellular carcinoma (hcc) in developed countries. |
| PubMedID- 21992928 | Prevalence and clinical significance of cryptosporidium infection in patients with hepatitis b virus-associated acute-on-chronic liver failure. |
| PubMedID- 24274835 | Study design and methods: plasma samples from 11 donors donating between july 2005 and june 2010, whose test results revealed recent infection with hepatitis b, were available for further analysis. |
| PubMedID- 26034769 | It should be noted that a high proportion of patients in this study cohort also had evidence of infection with hepatitis b (78%), which is perhaps not surprising due to shared parenteral mode of transmission. |
| PubMedID- 24926465 | Infectious causes were excluded, based on negative serological data for infection with cytomegalovirus, hepatitis b virus, hepatitis c virus, hepatitis a virus, and epstein-barr virus. |
| PubMedID- 22489261 | This review focuses on recent changes in the epidemiology, pathogenesis and clinical presentation of liver disease in hiv-infected patients, in the absence of co-infection with hepatitis b virus or hepatitis c virus, with a specific focus on issues relevant to low and middle income countries. |
| PubMedID- 24994007 | Background: infection with hepatitis b virus (hbv) during pregnancy may lead to perinatal transmission. |
| PubMedID- 25654087 | Risk factors for hcc include infection with hepatitis b (hbv) and hepatitis c viruses (hcv), history of diabetes mellitus, nonalcoholic fatty liver disease and cirrhosis, heavy alcohol consumption, and cigarette smoking . |
| PubMedID- 24397793 | Chronic infection with hepatitis b virus (hbv) is a major cause of death from cirrhosis and liver cancer, chiefly in south-east asia and sub-saharan africa . |
| PubMedID- 23484104 | Major risk factors for hcc include infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), alcoholic liver disease, and most probably nonalcoholic fatty liver disease 3. |
| PubMedID- 24521097 | The findings indicated that hospitalisation, elevated serum alanine aminotransferase levels, hcv infection and acceptance of the hepatitis b vaccine were the significant risk factors, whereas no consumption of alcohol, average monthly costs for patients less than or equal to 100 us dollars, and good health status of family caregivers were the protective factors. |
| PubMedID- 21813377 | Esld is increasingly recognized as a significant cause of morbidity and mortality among hiv-infected patients due to liver-related complications of co-infection with hepatitis b(hbv) and hepatitis c-virus (hcv). |
| PubMedID- 25309066 | Chronic infection with hepatitis b virus (hbv) leads to the development of hepatocellular carcinoma and/or chronic liver failure. |